Interpace Biosciences Files Proxy Statement

TL;DR

INTERPACE BIOSCIENCES (IDX) filed its proxy statement - shareholders vote soon.

AI Summary

Interpace Biosciences, Inc. filed a DEF 14A proxy statement on September 20, 2024. The filing pertains to the company's annual meeting and related corporate governance matters. The company, formerly known as Interpace Diagnostics Group, Inc. and PDI Inc., is incorporated in Delaware and headquartered in Parsippany, NJ.

Why It Matters

This filing provides shareholders with essential information regarding the company's governance, executive compensation, and voting matters, enabling informed participation in corporate decisions.

Risk Assessment

Risk Level: low — This is a routine proxy filing, not indicating immediate financial distress or significant operational changes.

Key Players & Entities

• INTERPACE BIOSCIENCES, INC. (company) — Registrant
• Interpace Diagnostics Group, Inc. (company) — Former Company Name
• PDI INC (company) — Former Company Name
• 20240920 (date) — Filing Date

FAQ

Key Financial Figures

• $0.01 — convertible preferred stock, par value $0.01 per share (the “ Series B Preferr

Filing Documents

• formdef14a.htm (DEF 14A) — 451KB
• formdef14a_001.jpg (GRAPHIC) — 29KB
• formdef14a_002.jpg (GRAPHIC) — 31KB
• formdef14a_003.jpg (GRAPHIC) — 28KB
• proxycard_001.jpg (GRAPHIC) — 628KB
• proxycard_002.jpg (GRAPHIC) — 352KB
• 0001493152-24-037669.txt ( ) — 1925KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 27 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 30 OTHER MATTERS 30 ADDITIONAL INFORMATION 30 i PROXY GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING Why are you receiving these proxy materials? We have made these materials available to you electronically in connection with the solicitation of proxies on behalf of our board of directors (the “ Board ”) for use at our 2024 Annual Meeting of Stockholders (the “ Annual Meeting ”). This Proxy so that you can make an informed decision. Why did I receive a notice in the mail regarding the Internet availability of proxy materials instead of a full set of proxy materials? In accordance with rules adopted by the Securities and Exchange Commission (“ SEC ”), we are providing access to our proxy materials over the Internet. Accordingly, we are sending a Notice Regarding the Availability of Proxy Materials for the Annual Meeting (the “ Notice ”) to our stockholders of record and beneficial owners as of the record date (for more information on the record date, see “Who is entitled to vote at the Annual Meeting?”). The mailing of the Notice to our stockholders is scheduled to begin on or about October 1, 2024. All stockholders will have the ability to access the proxy materials and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as amended (the “ Annual Report ”) on a website referred to in the Notice or to request to receive a printed set of the proxy materials and the Annual Report. Instructions on how to access the proxy materials over the Internet or to request a printed copy may be found in the Notice. Stockholders may also request to receive proxy materials and our Annual Report i

View Full Filing

View this DEF 14A filing on SEC EDGAR